NCT04775134 Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)
| NCT ID | NCT04775134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Covid19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2021-01-31 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2021-01-31 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to confirm or rule out the residual presence and viability of SARS- CoV-2 in the respiratory tract and lung parenchyma of patients previously infected with SARS-CoV-2. Presence and viability of SARS-CoV-2 in lung tissue will be assessed with reverse transcriptase-polymerase chain reaction (PCR) and viral culture. The histological location of residual SARS-CoV-2 will be determined with fluorescence immunohistochemistry and single molecule fluorescence in situ hybridization, targeting viral proteins and RNA respectively.
Eligibility Criteria
Inclusion Criteria: * Patient requires medically indicated pulmonary resection * Informed consent Exclusion Criteria: * Active SARS-CoV-2 infection/COVID-19 * No informed consent
Contact & Investigator
Laurens J Ceulemans, MD, PhD
PRINCIPAL INVESTIGATOR
UZ Leuven
Frequently Asked Questions
Who can join the NCT04775134 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Covid19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04775134 currently recruiting?
Yes, NCT04775134 is actively recruiting participants. Contact the research team at laurens.ceulemans@uzleuven.be for enrollment information.
Where is the NCT04775134 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT04775134 clinical trial?
NCT04775134 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Laurens J Ceulemans, MD, PhD at UZ Leuven. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.